GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Price-to-Free-Cash-Flow

Merck KGaA (Merck KGaA) Price-to-Free-Cash-Flow : 37.07 (As of Apr. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Price-to-Free-Cash-Flow?

As of today (2024-04-28), Merck KGaA's share price is $32.25. Merck KGaA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.87. Hence, Merck KGaA's Price-to-Free-Cash-Flow Ratio for today is 37.07.

The historical rank and industry rank for Merck KGaA's Price-to-Free-Cash-Flow or its related term are showing as below:

MKKGY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.36   Med: 26.09   Max: 41.63
Current: 37.51

During the past 13 years, Merck KGaA's highest Price-to-Free-Cash-Flow Ratio was 41.63. The lowest was 12.36. And the median was 26.09.

MKKGY's Price-to-Free-Cash-Flow is ranked worse than
64.98% of 494 companies
in the Drug Manufacturers industry
Industry Median: 21.8 vs MKKGY: 37.51

Merck KGaA's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.24. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.87.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Merck KGaA was -28.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -2.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 9.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 3.40% per year.

During the past 13 years, Merck KGaA's highest 3-Year average Free Cash Flow per Share Growth Rate was 239.90% per year. The lowest was -12.70% per year. And the median was 10.20% per year.


Merck KGaA Price-to-Free-Cash-Flow Historical Data

The historical data trend for Merck KGaA's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Price-to-Free-Cash-Flow Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.96 31.88 30.89 32.06 35.58

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.06 32.34 32.07 38.76 35.58

Competitive Comparison of Merck KGaA's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Price-to-Free-Cash-Flow falls into.



Merck KGaA Price-to-Free-Cash-Flow Calculation

Merck KGaA's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=32.25/0.87
=37.07

Merck KGaA's Share Price of today is $32.25.
Merck KGaA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.87.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Merck KGaA  (OTCPK:MKKGY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Merck KGaA Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (Merck KGaA) Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (Merck KGaA) Headlines

From GuruFocus